Manuel Arrojo

7.4k total citations
64 papers, 821 citations indexed

About

Manuel Arrojo is a scholar working on Clinical Psychology, Psychiatry and Mental health and Genetics. According to data from OpenAlex, Manuel Arrojo has authored 64 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Clinical Psychology, 19 papers in Psychiatry and Mental health and 13 papers in Genetics. Recurrent topics in Manuel Arrojo's work include Schizophrenia research and treatment (14 papers), Obsessive-Compulsive Spectrum Disorders (12 papers) and Genetic Associations and Epidemiology (10 papers). Manuel Arrojo is often cited by papers focused on Schizophrenia research and treatment (14 papers), Obsessive-Compulsive Spectrum Disorders (12 papers) and Genetic Associations and Epidemiology (10 papers). Manuel Arrojo collaborates with scholars based in Spain, United States and United Kingdom. Manuel Arrojo's co-authors include Javier Costas, Mario Páramo, Eduardo Paz, Pilar A. Sáiz, José de León, Ramón Ramos‐Ríos, Julio Brenlla, Enrique Baca‐García, Helen Dolengevich-Segal and M. Mercedes Pérez-Rodríguez and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Affective Disorders.

In The Last Decade

Manuel Arrojo

62 papers receiving 799 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Arrojo Spain 18 300 227 121 117 110 64 821
Margarita Rivera Spain 17 265 0.9× 264 1.2× 167 1.4× 97 0.8× 162 1.5× 34 1.0k
Erika L. Nurmi United States 16 181 0.6× 174 0.8× 99 0.8× 132 1.1× 105 1.0× 31 748
Florence Gressier France 20 233 0.8× 360 1.6× 106 0.9× 205 1.8× 115 1.0× 62 1.1k
José Antonio Monreal Spain 17 349 1.2× 241 1.1× 88 0.7× 75 0.6× 71 0.6× 84 917
Marc Ziegenbein Germany 19 305 1.0× 298 1.3× 165 1.4× 165 1.4× 121 1.1× 56 1.0k
Conrad Iyegbe United Kingdom 16 292 1.0× 187 0.8× 118 1.0× 113 1.0× 151 1.4× 33 903
Fernanda Pedrotti Moreira Brazil 19 210 0.7× 207 0.9× 85 0.7× 67 0.6× 116 1.1× 60 963
Javier Vázquez-Bourgón Spain 16 464 1.5× 142 0.6× 80 0.7× 99 0.8× 54 0.5× 77 793
Marc-Antoine Crocq France 11 179 0.6× 210 0.9× 100 0.8× 176 1.5× 82 0.7× 18 827
Akihito Uezato Japan 13 159 0.5× 193 0.9× 112 0.9× 84 0.7× 151 1.4× 26 728

Countries citing papers authored by Manuel Arrojo

Since Specialization
Citations

This map shows the geographic impact of Manuel Arrojo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Arrojo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Arrojo more than expected).

Fields of papers citing papers by Manuel Arrojo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Arrojo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Arrojo. The network helps show where Manuel Arrojo may publish in the future.

Co-authorship network of co-authors of Manuel Arrojo

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Arrojo. A scholar is included among the top collaborators of Manuel Arrojo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Arrojo. Manuel Arrojo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arrojo, Manuel, et al.. (2025). Evaluating the Real-World Pharmacokinetics of Risperidone ISM® in Routine Clinical Practice. Biomedicines. 13(2). 384–384. 1 indexed citations
3.
Arrojo, Manuel, et al.. (2024). Association between psychiatric admissions in patients with schizophrenia and IL-6 plasma levels polygenic score. European Archives of Psychiatry and Clinical Neuroscience. 274(7). 1671–1679. 5 indexed citations
4.
Cuevas, Carlos De las, Emílio J. Sanz, Christoph U. Correll, et al.. (2023). Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK. Schizophrenia Research. 268. 175–188. 10 indexed citations
5.
Raduà, Joaquim, Lydia Fortea, José Manuel Goikolea, et al.. (2023). Meta-analysis of the effects of adjuvant drugs in co-occurring bipolar and substance use disorder. PubMed. 17(4). 239–250. 2 indexed citations
6.
7.
Cuevas, Carlos De las, Manuel Arrojo, Can‐Jun Ruan, et al.. (2022). Clozapine-induced myocarditis in children and adolescents: a pharmacovigilance study using VigiBase and a systematic literature review. Expert Opinion on Drug Metabolism & Toxicology. 18(11). 715–727. 10 indexed citations
8.
Arrojo, Manuel, et al.. (2022). A Covid-19 outbreak in a Spanish long-term psychiatric hospital led to infections in 6 clozapine patients: elevations in their plasma clozapine levels. Revista de Psiquiatría y Salud Mental. 15(4). 290–292. 12 indexed citations
9.
Alonso, Pino, Manuel Arrojo, Eva Real, et al.. (2022). Neuropsychological performance and predictors of pharmacological treatment response in obsessive compulsive disorder. Journal of Affective Disorders. 317. 52–58. 5 indexed citations
10.
Vázquez, Fernando L., Patricia Otero, J. Antonio García-Casal, et al.. (2018). Efficacy of video game-based interventions for active aging. A systematic literature review and meta-analysis. PLoS ONE. 13(12). e0208192–e0208192. 45 indexed citations
11.
González‐Peñas, Javier, Manuel Arrojo, Eduardo Paz, et al.. (2015). Cumulative role of rare and common putative functional genetic variants at NPAS3 in schizophrenia susceptibility. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 168(7). 528–535. 4 indexed citations
12.
Suárez‐Rama, Jose Javier, Manuel Arrojo, Beatriz Sobrino, et al.. (2015). Resequencing and association analysis of coding regions at twenty candidate genes suggest a role for rare risk variation at AKAP9 and protective variation at NRXN1 in schizophrenia susceptibility. Journal of Psychiatric Research. 66-67. 38–44. 14 indexed citations
13.
Fernández‐Navarro, Pablo, María Luisa Barrigón, Jorge López‐Castromán, et al.. (2015). Suicide mortality trends in Galicia, Spain and their relationship with economic indicators. Epidemiology and Psychiatric Sciences. 25(5). 475–484. 8 indexed citations
14.
Flórez, Gerardo, Ana López‐Durán, Yolanda Triñanes, et al.. (2015). First-time admissions for opioid treatment: cross-sectional and descriptive study of new opioid users seeking treatment. Neuropsychiatric Disease and Treatment. 11. 2431–2431. 1 indexed citations
15.
García‐Portilla, María Paz, Leticia García-Álvarez, Manuel Arrojo, et al.. (2015). Predictive factors of functional capacity and real-world functioning in patients with schizophrenia. European Psychiatry. 30(5). 622–627. 37 indexed citations
16.
Al‐Halabí, Susana, María Paz García‐Portilla, Pilar A. Sáiz, et al.. (2012). Psychometric properties of the Spanish version of the Body Weight, Image and Self-Esteem Evaluation questionnaire in patients with severe mental disorders. Comprehensive Psychiatry. 53(8). 1237–1242. 4 indexed citations
17.
Becoña, Elisardo, et al.. (2012). Vida recreativa y consumo de cocaína y éxtasis en jóvenes. Psicología conductual = behavioral psychology: Revista internacional de psicología clínica y de la salud. 20(2). 245–262. 2 indexed citations
18.
Costas, Javier, Julio Sanjuán, Ramón Ramos‐Ríos, et al.. (2011). Interaction between COMT haplotypes and cannabis in schizophrenia: A case-only study in two samples from Spain. Schizophrenia Research. 127(1-3). 22–27. 45 indexed citations
19.
Baca‐García, Enrique, Concepción Vaquero‐Lorenzo, Helen Dolengevich-Segal, et al.. (2006). Association between obsessive–compulsive disorder and a variable number of tandem repeats polymorphism in intron 2 of the serotonin transporter gene. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31(2). 416–420. 32 indexed citations
20.
Baca‐García, Enrique, et al.. (2005). A pilot genetic study of the continuum between compulsivity and impulsivity in females: The serotonin transporter promoter polymorphism. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 29(5). 713–717. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026